Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Causaly logo — Unlock R&D productivity with the most complete AI platform f...

Causaly

Unlock R&D productivity with the most complete AI platform for life sciences.

Founded 2018 United Kingdom London, United Kingdom 118 employees Series B Total: $82.30M Biotechnology, Pharmaceutical

General Information

Company Name Causaly
Founded Year 2018
Location United Kingdom London, United Kingdom
Employees 118
Industries Biotechnology, Pharmaceutical
Funding Stage Series B
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Consulting Fee, Usage Based
Offices as of Oct 2026
London, United Kingdom
Social

BounceWatch is an independent company data service, not affiliated with Causaly. To contact Causaly, visit causaly.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Causaly compare?

A PDF of Causaly and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Causaly soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Oct 05, 2026

Causaly is participating in BioTechX Europe from October 6-8, 2026, where their team will be available for meetings and Alexander Schurer will be speaking.

Feature Release Sep 17, 2026

Causaly has launched a new feature, making its AI platform available directly within Microsoft 365 Copilot and Microsoft Teams for scientific teams.

Actively Hiring Sep 11, 2026

Hiring for 3 positions in the last 30 days.

Get alerts when Causaly shows new signals

About Causaly

Causaly, founded in 2018 and headquartered in the United Kingdom, is positioned at the intersection of biotechnology and pharmaceutical industries. The company aims to redefine human discovery boundaries through its transformative AI technologies. With the slogan "Unlock R&D productivity with the most complete AI platform for life sciences," Causaly is a pivotal resource for modern Life Science research organizations, enhancing the discovery-to-development pipeline in drug development.

The company's most recent financing round, a $60.00M Series B investment secured on 1 July 2023, underscores its promising growth trajectory. The investment consortium includes renowned entities such as Visionaries Club, Index Ventures, Marathon Venture Capital, and European Bank for Reconstruction and Development, among others. This robust backing reflects strong confidence in Causaly's potential to expedite the launch of life-changing therapies through accelerated data analysis and application.

Business keywords: AI Platform, Life Sciences, Drug Discovery, Biomedical Research, Natural Language Understanding, Knowledge Graphs, R&D Productivity, Decision-Making, Transformative AI, Research Acceleration, Laboratory Insights, Cognitive Amplification, Pharmaceuticals

Services & Products

AI-driven R&D Acceleration
Scientific Decision Support
Automated Scientific Workflows
Data Integration and Analysis
Research and Discovery Automation
Regulatory Submission Support

Target Customers

Pharmaceutical Companies Biotech Startups Research and Development Teams Clinical Researchers Data Scientists in Life Sciences Regulatory Compliance Teams

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $60.00M 8
Visionaries Club Index Ventures Marathon Venture Capital
Visionaries Club, Index Ventures +6
01 Jul 2023
Round Undisclosed -
01 Oct 2022
Series A $17.00M 4
Index Ventures Marathon Venture Capital Pentech Ventures
Index Ventures, Marathon Venture Capital +2
01 May 2021
Series A €4.30M 3
Marathon Venture Capital Pentech Ventures
Marathon Venture Capital, Pentech Ventures +1
01 Nov 2019
Seed $1.00M 5
Marathon Venture Capital
Marathon Venture Capital, Nadav Rosenberg +3
01 Jul 2018

Latest News

View All
Top 100 Rising European Startups for 2025 revealed — Businesscloud.co.uk
Top 100 Rising European Startups for 2025 revealed
Businesscloud.co.uk May 15, 2025
19 AI healthtechs to watch, according to VCs — Sifted
19 AI healthtechs to watch, according to VCs
Sifted Apr 05, 2024

Causaly Alternatives & Competitors

View All Alternatives
Causaly vs
Partex.AI Technology
Partex.AI Technology India

The experts in AI technology for drug discovery and development.

Series C
182 employees
AI, Analytics
Compare Causaly vs Partex.AI Technology
Causaly vs
AcademicLabs
AcademicLabs Belgium

AI-powered scientific intelligence platform for early-stage research and innovation scouting

Seed
15 employees
Analytics, Big Data
Compare Causaly vs AcademicLabs
Causaly vs
BenchSci
BenchSci Canada

We empower scientists with the world’s most advanced biomedical artificial intelligence.

Series D+
242 employees
AI, Biotechnology
Also compare with: Causaly vs Narrativa Narrativa View all alternatives

FAQ About Causaly

Unlock R&D productivity with the most complete AI platform for life sciences.
Causaly was founded in 2018.
Causaly is headquartered in London, United Kingdom.
Causaly operates in Biotechnology and Pharmaceutical. Its work centres on AI Platform, Life Sciences, Drug Discovery and Biomedical Research. Its customers include Pharmaceutical Companies, Biotech Startups and Research and Development Teams.
Causaly has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Consulting Fee and Usage Based.
Causaly has approximately 118 employees.
Causaly has completed 5 funding rounds, raising a total of $82.30M. The latest funding stage is Series B.
Causaly offers: AI-driven R&D Acceleration, Scientific Decision Support, Automated Scientific Workflows, Data Integration and Analysis, Research and Discovery Automation, Regulatory Submission Support.
Top alternatives and competitors to Causaly include Partex.AI Technology, AcademicLabs, BenchSci, Narrativa, Nextnet. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Causaly and Partex.AI Technology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Causaly, https://bouncewatch.com/company/causaly, updated 7 October 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes